Pre-emptive genomic surveillance of emerging ebolaviruses.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Jan 2020
Historique:
entrez: 30 1 2020
pubmed: 30 1 2020
medline: 20 2 2020
Statut: ppublish

Résumé

Genomic surveillance during ebolavirus outbreaks to elucidate transmission chains and develop diagnostic tests is delayed by the laborious development of variant-specific laboratory assays. We developed a new protocol combining 31 parallel PCR assays with Illumina/MinION-based sequencing, allowing generic ebolavirus genomic surveillance, validated using cell culture-derived Ebola, Reston, Sudan and Taï Forest virus at concentrations compatible with patient viral loads. Our approach enables pre-emptive genomic surveillance of ongoing and future ebolavirus outbreaks irrespective of variant divergence.

Identifiants

pubmed: 31992392
doi: 10.2807/1560-7917.ES.2020.25.3.1900765
pmc: PMC6988270
doi:

Substances chimiques

DNA, Viral 0
RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nature. 2015 Aug 6;524(7563):97-101
pubmed: 26083749
Science. 2014 Sep 12;345(6202):1369-72
pubmed: 25214632
Virus Evol. 2016 Jun 22;2(1):vew016
pubmed: 28694998
J Clin Invest. 2015 Dec;125(12):4421-8
pubmed: 26551677
Bull World Health Organ. 2016 Dec 1;94(12):880-892
pubmed: 27994281
Cell. 2015 Jun 18;161(7):1516-26
pubmed: 26091036
Cell Host Microbe. 2015 Dec 9;18(6):659-69
pubmed: 26651942
BMC Genomics. 2019 Feb 26;20(1):155
pubmed: 30808306
Nature. 2015 Aug 6;524(7563):93-6
pubmed: 25970247
Emerg Infect Dis. 2019 May;25(5):955-957
pubmed: 31002301
Viruses. 2015 Jun 17;7(6):3130-54
pubmed: 26090727
Nature. 2016 Feb 11;530(7589):228-232
pubmed: 26840485
mSphere. 2019 Jul 3;4(4):
pubmed: 31270168
Euro Surveill. 2019 Jan;24(4):
pubmed: 30696524
J Virol. 2017 Jan 3;91(2):
pubmed: 27847361
Int J Infect Dis. 2016 Jan;42:34-39
pubmed: 26523640
Nat Rev Microbiol. 2017 Mar;15(3):183-192
pubmed: 28090077

Auteurs

Ignacio Postigo-Hidalgo (I)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Virology, Berlin, Germany.

Carlo Fischer (C)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Virology, Berlin, Germany.

Andres Moreira-Soto (A)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Virology, Berlin, Germany.

Patricia Tscheak (P)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Virology, Berlin, Germany.

Michael Nagel (M)

Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, Bonn, Germany.

Markus Eickmann (M)

German Centre for Infection Research (DZIF), partner site Giessen - Marburg - Langen, Germany.
Institute of Virology, Philipps-Universität Marburg, Marburg, Germany.

Jan Felix Drexler (JF)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Virology, Berlin, Germany.
German Centre for Infection Research (DZIF), associated partner Charité - Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH